For decades, Group O blood has been considered the universal solution for emergency transfusion. In situations where a patient’s blood type is unknown, O-negative red blood cells have been the default choice, minimizing the risk of acute hemolytic transfusion reactions and allowing rapid response in critical situations.

Leadership in clinical laboratories is often discussed in terms of technical expertise, regulatory knowledge, and operational oversight. All of those are essential. But some of the most significant risks in laboratory environments don’t originate from a lack of technical capability. They emerge from leadership patterns—subtle, often unintentional behaviors that influence how teams operate, communicate, and…

When clinicians review a laboratory result, they rarely see the infrastructure that supports it. A hemoglobin value, antibody screen, or molecular test result appears as a simple data point in the electronic medical record. But behind that single result is a complex operational framework designed to ensure the test was performed correctly, consistently, and in…

The diagnostics industry has never been more innovative. New assays emerge every year promising earlier detection, improved clinical sensitivity, and more precise treatment decisions. Advances in molecular diagnostics, immunoassay design, and multi-omic platforms are reshaping how disease is detected and managed.